FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

386919002: rituximab (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
1461097016 Rituximab (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
1481033012 Rituximab en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
193051000077119 rituximab fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Common French translation module (core metadata concept)
469711000077116 rituximab (substance) fr Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT Common French translation module (core metadata concept)


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Rituximab (substance) est un(e) (attribut) Antineoplastic agent (substance) true Inferred relationship Some
Rituximab (substance) est un(e) (attribut) Monoclonal antibody (substance) true Inferred relationship Some
Rituximab (substance) est un(e) (attribut) Immunosuppressant (substance) true Inferred relationship Some
Rituximab (substance) est un(e) (attribut) Monoclonal antibody agent (substance) false Inferred relationship Some
Rituximab (substance) Has disposition (attribute) Immunomodulator (disposition) true Inferred relationship Some
Rituximab (substance) est un(e) (attribut) anticorps monoclonal chimérique souris-humain d'isotype IgG false Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Rituximab only product a pour principe actif (attribut) True Rituximab (substance) Inferred relationship Some 1
Rituximab only product in parenteral dose form a pour principe actif (attribut) True Rituximab (substance) Inferred relationship Some 1
Product containing precisely rituximab 10 milligram/1 milliliter conventional release solution for infusion (clinical drug) Has precise active ingredient True Rituximab (substance) Inferred relationship Some 1
Product containing precisely rituximab 10 milligram/1 milliliter conventional release solution for infusion (clinical drug) Has basis of strength substance (attribute) True Rituximab (substance) Inferred relationship Some 1
R-CEOP (rituximab, cyclophosphamide, etoposide, vincristine, prednisone) antineoplastic chemotherapy substance utilisée (attribut) True Rituximab (substance) Inferred relationship Some 2
Rituximab 10 mg/mL solution for injection Has precise active ingredient True Rituximab (substance) Inferred relationship Some 1
Rituximab 10 mg/mL solution for injection Has basis of strength substance (attribute) True Rituximab (substance) Inferred relationship Some 1
Product containing precisely rituximab 10 milligram/1 milliliter conventional release solution for infusion and/or injection (clinical drug) Has precise active ingredient True Rituximab (substance) Inferred relationship Some 1
Product containing precisely rituximab 10 milligram/1 milliliter conventional release solution for infusion and/or injection (clinical drug) Has basis of strength substance (attribute) True Rituximab (substance) Inferred relationship Some 1
Product containing rituximab (medicinal product) a pour principe actif (attribut) True Rituximab (substance) Inferred relationship Some 1
Rituximab 10mg/mL injection concentrate 10mL vial (product) a pour principe actif (attribut) False Rituximab (substance) Inferred relationship Some
Rituximab 10mg/mL infusion concentrate 50mL vial (product) a pour principe actif (attribut) False Rituximab (substance) Inferred relationship Some
Rituximab 500mg infusion concentrate vial (product) a pour principe actif (attribut) False Rituximab (substance) Inferred relationship Some
Rituximab 100mg infusion concentrate vial (product) a pour principe actif (attribut) False Rituximab (substance) Inferred relationship Some
Adverse reaction to rituximab administered by infusion Causative agent True Rituximab (substance) Inferred relationship Some 1
Product containing rituximab in parenteral dose form (medicinal product form) a pour principe actif (attribut) True Rituximab (substance) Inferred relationship Some 1
Rituximab, ifosfamide, carboplatin and etoposide chemotherapy regimen (regime/therapy) substance utilisée (attribut) True Rituximab (substance) Inferred relationship Some 7
Rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone chemotherapy regimen (regime/therapy) substance utilisée (attribut) True Rituximab (substance) Inferred relationship Some 6
Rituximab therapy (procedure) substance utilisée (attribut) True Rituximab (substance) Inferred relationship Some 2
Rituximab 100 mg/10 mL solution for infusion vial Has basis of strength substance (attribute) False Rituximab (substance) Inferred relationship Some 1
Rituximab 100 mg/10 mL solution for infusion vial Has precise active ingredient False Rituximab (substance) Inferred relationship Some 1
Product containing precisely rituximab 500 milligram/50 milliliter conventional release solution for infusion vial (clinical drug) Has basis of strength substance (attribute) False Rituximab (substance) Inferred relationship Some 1
Product containing precisely rituximab 500 milligram/50 milliliter conventional release solution for infusion vial (clinical drug) Has precise active ingredient False Rituximab (substance) Inferred relationship Some 1

Reference Sets

Canada English language reference set (foundation metadata concept)

GB English

US English

Back to Start